Using a mouse liver fibrosis model induced by intraperitoneal injection of CCL4, it was observed that oral quercetin treatment resulted in lower portal inflammation scores, decreased serum enzymes ALT and AST, as well as reduced collagen deposition and fibrosis scores. This evidence concerns the gene CCL4 and Hepatic fibrosis.